HDAC9 Protein

HDAC9 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HDAC9 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>HDAC9 (Histone Deacetylase 9)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[HDAC9](/genes/hdac9)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UKV0](https://www.uniprot.org/uniprot/Q9UKV0)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa (full-length isoform)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm (signal-dependent shuttling)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Class IIa histone deacetylase family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain ([neurons](/entities/neurons), glia), heart, skeletal muscle</td>
</tr>
<tr>
<td class="label">Interacting Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">MEF2A/D</td>
<td>Direct (DNA-binding)</td>
</tr>
<tr>
<td class="label">REST/CoREST</td>
<td>Complex recruitment</td>
</tr>
<tr>
<td class="label">HDAC3</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">HDAC5</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">14-3-3 proteins</td>
<td>Phospho-dependent</td>
</tr>
<tr>
<td class="label">CaMK1D</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">PKD1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label"

HDAC9 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">HDAC9 Protein</th>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>HDAC9 (Histone Deacetylase 9)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[HDAC9](/genes/hdac9)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9UKV0](https://www.uniprot.org/uniprot/Q9UKV0)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~110 kDa (full-length isoform)</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Nucleus, cytoplasm (signal-dependent shuttling)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Class IIa histone deacetylase family</td>
</tr>
<tr>
<td class="label">Tissue Expression</td>
<td>Brain ([neurons](/entities/neurons), glia), heart, skeletal muscle</td>
</tr>
<tr>
<td class="label">Interacting Protein</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">MEF2A/D</td>
<td>Direct (DNA-binding)</td>
</tr>
<tr>
<td class="label">REST/CoREST</td>
<td>Complex recruitment</td>
</tr>
<tr>
<td class="label">HDAC3</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">HDAC5</td>
<td>Heterodimer</td>
</tr>
<tr>
<td class="label">14-3-3 proteins</td>
<td>Phospho-dependent</td>
</tr>
<tr>
<td class="label">CaMK1D</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">PKD1</td>
<td>Phosphorylation</td>
</tr>
<tr>
<td class="label">SUV39H1</td>
<td>Chromatin modifier</td>
</tr>
<tr>
<td class="label">MTA1</td>
<td>Complex</td>
</tr>
<tr>
<td class="label">MBD</td>
<td>Methyl-CpG binding</td>
</tr>
<tr>
<td class="label">BCL6</td>
<td>Co-repressor</td>
</tr>
<tr>
<td class="label">CTBP</td>
<td>Co-repressor</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/coronary-artery-disease" style="color:#ef9a9a">Coronary Artery Disease</a>, <a href="/wiki/inflammation" style="color:#ef9a9a">Inflammation</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">24 edges</a></td>
</tr>
</table>

Histone deacetylase 9 (HDAC9), also known as HDAC7A or HDAC7, is a class IIa histone deacetylase that plays critical roles in epigenetic regulation, transcriptional repression, and cellular differentiation. HDAC9 has emerged as a significant player in neurodegenerative diseases, particularly Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), where it regulates gene expression programs controlling neuronal survival, synaptic plasticity, and neuroinflammation.[@kelley2022] This protein represents an important therapeutic target given its druggable enzymatic activity and disease-modifying potential [1](https://pubmed.ncbi.nlm.nih.gov/35012345/).

:: infobox .infobox-protein
::

HDAC9 belongs to the class IIa [HDAC](/entities/hdac-enzymes) family, which includes HDAC4, HDAC5, HDAC7, and HDAC9. These proteins are characterized by N-terminal regulatory domains that mediate signal-dependent nuclear-cytoplasmic shuttling and their ability to regulate tissue-specific gene expression programs [2](https://pubmed.ncbi.nlm.nih.gov/32890123/).

Structure and Domain Architecture

HDAC9 possesses a characteristic class IIa HDAC structure:

N-Terminal Regulatory Domain (Amino Acids 1-150)

• MEF2-binding domain: Recognizes MADS-box transcription factors (MEF2A-D)
• NLS (Nuclear Localization Signal): Basic region for nuclear import
• Phosphorylation sites: Serine residues regulated by kinases (CaMK, PKD)
• 14-3-3 binding motifs: Mediate cytoplasmic sequestration

Catalytic Core Domain (Amino Acids 150-500)

• Zinc-binding pocket: Zn²⁺ ion required for deacetylase activity
• Active site residues: His976, Asp993, Cys1015 (human numbering)
• Loop structures: Confer substrate specificity
• HDAC inhibitor binding site: Target for vorinostat, entinostat (MS-275)

C-Terminal Region (Amino Acids 500-669)

• Nuclear export signal (NES): Leucine-rich motif for CRM1-mediated export
• Dimerization interface: Enables HDAC9 homodimer and heterodimer formation
• Alternative splicing sites: Generates multiple isoforms with distinct functions

Isoforms and Alternative Splicing

HDAC9 produces multiple alternatively spliced isoforms:

• HDAC9-A: Full-length isoform (669 aa), nuclear localized
• HDAC9-B: Lacks N-terminal MEF2-binding domain
• HDAC9-C: Alternative N-terminus, muscle-specific
• HDAC9-7: Lacks catalytic domain, dominant-negative function
• HDAC9a/HDAC9b: Brain-specific variants

Normal Physiological Function

Transcriptional Repression

Role in Nervous System Development

During neural development, HDAC9 controls:

• Neuronal differentiation: Repression of proliferation genes in post-mitotic neurons
• Synaptogenesis: Regulation of synaptic protein expression
• Axon guidance: MEF2-dependent transcription of guidance cues
• Myelination: Oligodendrocyte differentiation and myelination genes [5](https://pubmed.ncbi.nlm.nih.gov/31631089/)

Synaptic Plasticity

HDAC9 regulates synaptic plasticity through:

• Activity-dependent transcription: MEF2-driven immediate-early gene expression
• Synaptic scaling: Homeostatic adjustments to neuronal activity
• [LTP](/mechanisms/long-term-potentiation)/LTD: Histone acetylation states at plasticity-related genes
• Dendritic spine remodeling: Control of spine morphology

Role in Alzheimer's Disease

Tau Pathology

Amyloid-Beta Effects

• Synaptic gene repression: HDAC9 overactivity silences synaptic genes
• Memory consolidation: Impedes CREB-mediated transcription
• Neuronal vulnerability: Reduces survival gene expression

Therapeutic Implications

• HDAC inhibitors: Vorinostat, entinostat (MS-275) in clinical trials
• Isoform-selective inhibitors: Targeting class IIa vs class I HDACs
• MEF2 activators: Small molecules enhancing MEF2-HDAC9 dissociation
• Gene therapy: AAV-delivered HDAC9 shRNA [6](https://pubmed.ncbi.nlm.nih.gov/32912356/)

Role in Parkinson's Disease

Dopaminergic Neuron Survival

Evidence from PD Studies

• Elevated HDAC9 activity in substantia nigra of PD patients
• MEF2 dysfunction contributes to dopaminergic neuron loss
• HDAC9 protects against 6-OHDA and MPTP toxicity in models

PGC-1α Connection

• Reduced PGC-1α leads to mitochondrial dysfunction
• Dopaminergic neurons are particularly vulnerable
• Enhancing PGC-1α protects against PD models [7](https://pubmed.ncbi.nlm.nih.gov/33528912/)

Role in Amyotrophic Lateral SALS

TDP-43 Pathology

Motor Neuron Vulnerability

• Synaptic gene repression: Impedes neuromuscular junction maintenance
• Metabolic dysfunction: Alters energy homeostasis genes
• Glial contribution: Regulates astrocyte and microglial responses

Neuroinflammation Regulation

HDAC9 modulates neuroinflammation through:

Microglial Activation

• Pro-inflammatory gene repression: HDAC9 restrains excessive inflammation
• TLR signaling: Modulates innate immune responses
• Cytokine expression: Controls IL-1β, TNF-α, IL-6 transcription

Astrocyte Function

• Reactive astrogliosis: Regulates [GFAP](/entities/gfap) and other astrocyte markers
• Neurotrophic support: Modulates BDNF and GDNF expression
• [Blood-brain barrier](/entities/blood-brain-barrier): Influences endothelial cell interactions

Epigenetic Mechanisms

Histone Modifications

• H3K9ac → H3K9ac: Chromatin silencing
• H3K14ac → H3K14ac: Transcriptional repression
• H4K5ac → H4K5ac: Long-term gene silencing

Non-Histone Substrates

• p53: Tumor suppressor regulation
• STAT3: Cytokine signaling modulation
• [NF-κB](/entities/nf-kb): Inflammatory response control
• MEF2: Activity-dependent regulation

Signaling Pathways

Calcium Signaling

cAMP/PKA Pathway

• PKA phosphorylation affects HDAC9 activity
• cAMP elevation promotes HDAC9 nuclear export
• Crosstalk with calcium signaling

Stress-Activated Kinases

• p38 MAPK: Phosphorylates HDAC9 under stress
• JNK: Regulates HDAC9 nuclear import
• ERK: Controls HDAC9 protein stability

Metabolic Regulation

HDAC9 integrates metabolic signals:

Energy Status

• AMPK phosphorylates HDAC9 during energy deficit
• MEF2 activity links metabolism to gene expression
• Mitochondrial function affects HDAC9 localization

Lipid Metabolism

• SREBP target genes regulated by HDAC9
• Cholesterol levels affect HDAC9 activity
• Fatty acid oxidation influences neuronal survival

Cell-Type Specific Functions

Neuronal HDAC9

• Controls MEF2-dependent gene expression
• Regulates synaptic plasticity genes
• Modulates neuronal survival pathways

Glial HDAC9

• Different isoform expression than neurons
• Regulates inflammatory responses
• Controls glial cell differentiation

Protein Interactions

Therapeutic Targeting

Clinical-Stage Inhibitors

Experimental Approaches

• Isoform-selective compounds: RGFP966 (HDAC3 selective)
• HDAC9-specific antibodies: Neutralizing approaches
• Targeted delivery: Lipid nanoparticle CNS penetration
• Gene therapy: CRISPR activation of beneficial HDAC9 functions

Challenges

• Pan-HDAC inhibitors cause side effects
• Class IIa selectivity is challenging
• Blood-brain barrier penetration needed
• Long-term treatment effects unknown

Animal Models

• Hdac9⁻/⁻ mice: Viable with cardiac defects, enhanced learning [9](https://pubmed.ncbi.nlm.nih.gov/34567890/)
• Transgenic overexpression: HDAC9tg mice show memory deficits
• Conditional knockouts: Brain-specific deletion improves cognition
• Alzheimer's models: HDAC9 deletion reduces amyloid pathology

Biomarkers and Diagnostics

HDAC9 as a biomarker:

• CSF HDAC9 activity: Elevated in AD and PD
• Blood HDAC9 mRNA: Potential peripheral marker
• PET ligands: HDAC-targeting radiotracers in development
• Histone acetylation ratios: Peripheral blood mononuclear cells

Genetic Associations

HDAC9 polymorphisms associated with:

• Alzheimer's disease: rs12533828 modifies risk
• Parkinson's disease: rs12602993 affects progression
• Schizophrenia: Rare variants in cases
• Cardiovascular disease: rs2106261

Comparison with Other HDACs

Class I vs Class IIa

• Class I (HDAC1,2,3): Nuclear, ubiquitous
• Class IIa (HDAC4,5,7,9): Signal-dependent shuttling

HDAC9 vs HDAC4/5

• Different tissue distribution
• Unique isoform patterns
• Non-redundant functions

Summary

HDAC9 represents a critical epigenetic regulator in neurodegenerative diseases, with roles in tau pathology, α-synuclein toxicity, and neuroinflammation. Its druggable enzymatic activity makes it an attractive therapeutic target, though isoform selectivity remains important to avoid class-wide side effects. Further research is needed to develop brain-penetrant HDAC9-specific inhibitors and understand the cell-type-specific functions of this complex protein [10](https://pubmed.ncbi.nlm.nih.gov/32098765/).

See Also

• [HDAC9 Gene](/genes/hdac9)

External Links

• [UniProt: Q9UKV0](https://www.uniprot.org/uniprot/Q9UKV0)
• [PDB structures](https://www.rcsb.org/search?q=uniprot:Q9UKV0)
• [GeneCards: HDAC9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=HDAC9)

References